Tuesday, November 20, 2018 NIAID-Supported Scientists Unveil New Vaccine Testing Platform Using Human Tissue NIAID-supported scientists have developed a new modeling system for testing age-specific human immune responses to vaccines, according to a study published today in Frontiers in Immunology. Study authors from the Precision Vaccines Program at Boston Children's Hospital, directed by Ofer Levy, MD, PhD, report the three-dimensional human tissue culture construct is designed to enable researchers to test, evaluate and select human vaccine candidates for target populations, such as newborns and the elderly. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107